These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 15172634)
21. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006 [TBL] [Abstract][Full Text] [Related]
22. Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. de Bree R; Takes RP; Castelijns JA; Medina JE; Stoeckli SJ; Mancuso AA; Hunt JL; Rodrigo JP; Triantafyllou A; Teymoortash A; Civantos FJ; Rinaldo A; Pitman KT; Hamoir M; Robbins KT; Silver CE; Hoekstra OS; Ferlito A Head Neck; 2015 Dec; 37(12):1829-39. PubMed ID: 24954811 [TBL] [Abstract][Full Text] [Related]
23. Can molecular markers predict local, regional and distant metastasis in head and neck cancer? Haffty BG Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904 [No Abstract] [Full Text] [Related]
24. Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma. Elsheikh MN; Rinaldo A; Hamakawa H; Mahfouz ME; Rodrigo JP; Brennan J; Devaney KO; Grandis JR; Ferlito A Head Neck; 2006 Sep; 28(9):842-9. PubMed ID: 16691557 [TBL] [Abstract][Full Text] [Related]
25. [Incidental metastases of well-differentiated thyroid carcinoma in lymph nodes of patient with squamous cell head and neck cancer: case report with review of the literature]. Dequanter D; Lothaire P Rev Med Brux; 2008; 29(5):487-9. PubMed ID: 19055122 [TBL] [Abstract][Full Text] [Related]
26. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782 [TBL] [Abstract][Full Text] [Related]
27. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Layland MK; Sessions DG; Lenox J Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872 [TBL] [Abstract][Full Text] [Related]
28. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Mannello F Cancer; 2003 Jan; 97(1):201-3; author reply 203-4. PubMed ID: 12491521 [No Abstract] [Full Text] [Related]
29. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma. Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454 [TBL] [Abstract][Full Text] [Related]
30. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764 [TBL] [Abstract][Full Text] [Related]
31. Management of the N0 neck--reference or preference. Wei WI; Ferlito A; Rinaldo A; Gourin CG; Lowry J; Ho WK; Leemans CR; Shaha AR; Suárez C; Clayman GL; Robbins KT; Bradley PJ; Silver CE Oral Oncol; 2006 Feb; 42(2):115-22. PubMed ID: 15979931 [TBL] [Abstract][Full Text] [Related]
32. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology]. Remenár E Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182 [TBL] [Abstract][Full Text] [Related]
34. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival? Almadori G; Bussu F; Paludetti G Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030 [TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted MRI in head and neck cancer. Hermans R; Vandecaveye V JBR-BTR; 2007; 90(4):264-7. PubMed ID: 17966242 [TBL] [Abstract][Full Text] [Related]
36. Skin metastases from a head and neck carcinoma: a prognostic factor? Dequanter D; Mboti FB; Lothaire P; Andry G B-ENT; 2005; 1(3):113-5. PubMed ID: 16255495 [TBL] [Abstract][Full Text] [Related]
37. [Regional metastases of head and neck cutaneous squamous cell carcinoma]. de Heer AR; Bouman H; Gerritsen MJ; Ingels KJ; Kaanders JH; Takes RP Ned Tijdschr Geneeskd; 2008 Dec; 152(49):2645-9. PubMed ID: 19137960 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646 [TBL] [Abstract][Full Text] [Related]
39. Lymphatic vessel density in correlation to lymph node metastasis in head and neck squamous cell carcinoma. Frech S; Hörmann K; Riedel F; Götte K Anticancer Res; 2009 May; 29(5):1675-9. PubMed ID: 19443385 [TBL] [Abstract][Full Text] [Related]
40. Personalizing cancer care: updates on head and neck cancer. de Souza JA; Cohen EE Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]